会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • IMPLANTABLE HEART STIMULATOR USING END-DIASTOLIC PRESSURE (EDP)
    • 使用终末压力(EDP)的可植入心脏刺激器
    • WO2011071427A1
    • 2011-06-16
    • PCT/SE2009/051396
    • 2009-12-09
    • ST. JUDE MEDICAL ABBLOMQVIST, Andreas
    • BLOMQVIST, Andreas
    • A61N1/365A61N1/37A61B5/053
    • A61B5/053A61N1/36521A61N1/36564
    • Implantable heart stimulator comprising a control unit including a memory, a sensing unit, a pulse stimulation unit adapted to generate stimulation pulses separated by a variable predetermined pacing interval (PI), and also a method in a heart stimulator. The heart stimulator is adapted to be connected to one or many heart electrode leads provided with stimulating and sensing electrodes in order to stimulate heart tissue by said stimulation pulses and sense electrical heart events. The heart stimulator comprises a control parameter measurement unit adapted to derive a control parameter value indicative of end- diastolic pressure (EDP). At specified intervals, the control unit is adapted to vary the predetermined pacing interval (PI) according to a predetermined pacing interval (PI) search session scheme, and that control parameter values are determined, by said control parameter measurement unit at the different pacing intervals tested during said PI search session, and in that determined control parameter values and corresponding pacing intervals are stored in said memory. The maximum control parameter value obtained during one PI search session is determined and the corresponding pacing interval, denoted PI opt , is identified and used when stimulating the heart resulting in a maximal end-diastolic pressure.
    • 可植入心脏刺激器,其包括控制单元,其包括存储器,感测单元,适于产生由可变预定起搏间隔(PI)分离的刺激脉冲的脉冲刺激单元,以及心脏刺激器中的方法。 心脏刺激器适于连接到设置有刺激和感测电极的一个或多个心脏电极引线,以便通过所述刺激脉冲刺激心脏组织并感测电心脏事件。 心脏刺激器包括适于导出指示舒张末期压力(EDP)的控制参数值的控制参数测量单元。 以规定的间隔,控制单元适于根据预定的起搏间隔(PI)搜索会话方案来改变预定的起搏间隔(PI),并且通过所述控制参数测量单元以不同的起搏间隔确定控制参数值 在所述PI搜索会话期间进行测试,并且将所确定的控制参数值和相应的起搏间隔存储在所述存储器中。 确定在一个PI搜索会话期间获得的最大控制参数值,并且在刺激心脏导致最大舒张末期压力时识别并使用表示为PIopt的相应起搏间隔。
    • 3. 发明申请
    • SELECTIVE HEART PACING
    • 选择性心脏病
    • WO2010036151A1
    • 2010-04-01
    • PCT/SE2008/000523
    • 2008-09-23
    • ST.JUDE MEDICAL ABBLOMQVIST, Andreas
    • BLOMQVIST, Andreas
    • A61N1/365A61N1/37
    • A61N1/36585A61N1/3682A61N1/3702
    • An implantable medical device (100) measures an AV delay in connection with measurement of N physiological patient parameters. The parameters are used for identifying a sub-space (25) of an N -dimensional parameter space (20). An expected AV delay is assigned to the identified sub- space (25) based on the measured AV delay, where the parameter space (20) with expected AV delays constitute decision support information to be used by the device (100) for performing a selective heart pacing. This selective pacing is performed based on a priori probability determined using the support information and a measured set of N parameters. The a priori probability represents the probability of successful AV conduction at a current patient condition determined based on the measured parameters.
    • 可植入医疗装置(100)测量与N个生理学患者参数的测量有关的AV延迟。 这些参数用于识别N维参数空间(20)的子空间(25)。 基于所测量的AV延迟,预期的AV延迟被分配给所识别的子空间(25),其中具有预期的AV延迟的参数空间(20)构成要由设备(100)使用以执行选择性的决策支持信息 心脏起搏 基于使用支持信息确定的先验概率和N个参数的测量集来执行该选择性起搏。 先验概率表示在基于所测量的参数确定的当前患者状况下AV传导成功的概率。
    • 9. 发明申请
    • IMPLANTABLE MEDICAL DEVICE FOR MONITORING LUNG DEFICIENCY
    • 用于监测肺功能不全的可植入医疗装置
    • WO2008147253A1
    • 2008-12-04
    • PCT/SE2007/000511
    • 2007-05-28
    • ST. JUDE MEDICAL ABBLOMQVIST, Andreas
    • BLOMQVIST, Andreas
    • A61N1/37A61N1/365A61B5/0205
    • A61N1/36521A61B5/0205A61B5/076A61B5/0809A61N1/3601A61N1/36557
    • The invention concerns an implantable medical device (10) for monitoring a lung deficiency in a patient. The device (10) comprises a housing (12) and a control circuit (14) located within the housing (12). The control circuit (14) is configured to be able to analyse one or more signals which represent the breathing of said patient. The control circuit (14) is also configured to be able to monitor a relationship between an expiratory phase and an inspiratory phase of the breathing cycle, or an analogous relationship, and to monitor a change in said lung deficiency by monitoring a change in said relationship. The invention also concerns an implantable medical system including such an implantable medical device (10) as well as a method of monitoring a lung deficiency in a patient.
    • 本发明涉及一种用于监测患者的肺缺血的可植入医疗装置(10)。 装置(10)包括壳体(12)和位于壳体(12)内的控制电路(14)。 控制电路(14)被配置为能够分析代表所述患者的呼吸的一个或多个信号。 控制电路(14)还被配置为能够监测呼吸周期的呼气阶段和吸气阶段之间的关系或类似的关系,并且通过监视所述关系的变化来监测所述肺缺乏的变化 。 本发明还涉及包括这种可植入医疗装置(10)的可植入医疗系统以及监测患者的肺缺血的方法。